ライフサイエンスコーパス: immunohistochemical staining

1 vity and efficiency compared to conventional immunohistochemical staining.

2 bellar vermal activation as indexed by c-Fos immunohistochemical staining.

3 ging-based small-scale dosimetry, along with immunohistochemical staining.

4 s tissues by PCR, in situ hybridization, and immunohistochemical staining.

5 elioma, on the basis of tumor morphology and immunohistochemical staining.

6 rafts were analyzed using flow cytometry and immunohistochemical staining.

7 d by real-time polymerase chain reaction and immunohistochemical staining.

8 validate three of these (of three tested) by immunohistochemical staining.

9 mented melanocytes from melanophages without immunohistochemical staining.

10 was examined by flow cytometric analysis and immunohistochemical staining.

11 was also observed in normal human tissues by immunohistochemical staining.

12 analyses of Oncomine and GEO databases, and Immunohistochemical staining.

13 s from patients with OCSCC were evaluated by immunohistochemical staining.

14 corneal endothelium, a finding confirmed by immunohistochemical staining.

15 uminescence imaging and further confirmed by immunohistochemical staining.

16 antigen were evaluated by histochemical and immunohistochemical staining.

17 yed for PDE5 expression using immunoblot and immunohistochemical staining.

18 yzed by real-time PCR, western blotting, and immunohistochemical staining.

19 ioluminescence imaging (BLI) and verified by immunohistochemical staining.

20 ematoxylin and eosin-stained biopsies and by immunohistochemical staining.

21 o be up-regulated by quantitative RT-PCR and immunohistochemical staining.

22 e determined by semiquantitative analysis of immunohistochemical staining.

23 re observed in lower genital tract tissue by immunohistochemical staining.

24 -transcriptase polymerase chain reaction and immunohistochemical staining.

25 obes were collected to make cryosections for immunohistochemical staining.

26 mined by polymerase chain reaction (PCR) and immunohistochemical staining.

27 bility to tissue processing for histological/immunohistochemical staining.

28 g quantitative polymerase chain reaction and immunohistochemical staining.

29 and survival, which was further validated by immunohistochemical staining.

30 d for somatostatin receptor subtype-2 (sst2) immunohistochemical staining.

31 are based on interpretation of, for example, immunohistochemical staining.

32 fied by RNA array profiling and confirmed by immunohistochemical staining.

33 tion and Purkinje cell loss, visualized with immunohistochemical stainings.

34 Immunohistochemical staining 4 months after injection sh

35 Immunohistochemical staining against 5-HT revealed a hig

36 Immunohistochemical staining against podoplanin and intr

37 Based on immunohistochemical stainings against synapsin and serot

38 Immunohistochemical staining allowed us to distinguish l

39 Immunohistochemical staining also showed co-localization

40 Tumor expression of IL-20 was assessed by immunohistochemical staining among 198 patients with inv

41 rt (489) of patients with breast tumor using immunohistochemical staining and by a meta-analysis of g

42 Immunohistochemical staining and chromatin immunoprecipi

43 We performed double immunohistochemical staining and clonotypic T cell recep

44 Immunohistochemical staining and confocal microscopy wer

45 and 112 various types of ovarian cancers via immunohistochemical staining and examined LINE-1 promote

46 Immunohistochemical staining and fluorescence-activated

47 MP-2 knock-out mice for NFATc1 expression by immunohistochemical staining and found significant reduc

48 -PSMA PET/CT findings and PSMA expression in immunohistochemical staining and generate a cutoff value

49 Consistently, immunohistochemical staining and in vitro binding assays

50 A wide array of histological and immunohistochemical staining and mRNA-based gene express

51 ial biopsies (n = 50) and spleen (n = 11) by immunohistochemical staining and on erythrocytes by flow

52 h DTI in vivo, corroborated with axon/myelin immunohistochemical staining and retrograde fluorogold l

53 ments, HCV-positive cells were identified by immunohistochemical staining and the number of HCV-posit

54 Immunohistochemical staining and Western blot analyses s

55 Immunohistochemical staining and western blot analysis d

56 was validated in more than 300 tumors using immunohistochemical staining and western blot.

57 Immunohistochemical stainings and agonist applications s

58 Histological examination was performed by immunohistochemical staining, and cardiac function was a

59 Histological studies, immunohistochemical staining, and flatmount choroids for

60 Real-time PCR, immunohistochemical staining, and flow cytometry were em

61 Autoradiography, immunohistochemical staining, and HGF ELISA assays confi

62 of eosinophils, eosinophil peroxidase (EPX) immunohistochemical staining, and mast cells.

63 vations, however, predated radioimmunoassay, immunohistochemical staining, and other molecular studie

64 We also used immunoblot analysis, immunohistochemical staining, and other tools to study u

65 was studied in the healthy mouse retina via immunohistochemical stainings, and immunoreactivity prof

66 Next, using an Ai9/td reporter and immunohistochemical staining, annulus fibrosus and nucle

67 e-specific embryonic antigen-4 (SSEA-4), and immunohistochemical staining confirmed that 38/55 (69%)

68 Immunohistochemical staining confirmed that cardiac myoc

69 Immunohistochemical staining confirmed the correlation o

70 C cirrhotic livers and immunoflourescent and immunohistochemical staining confirms that HSCs express

71 Here, we report immunohistochemical staining data for AMPA and GABAA/B r

72 Here, we report immunohistochemical staining data for the GABA(A) alpha1

73 Immunohistochemical staining demonstrated that 14.6% of

74 Immunohistochemical staining demonstrated that Ebf3 and

75 Immunohistochemical staining demonstrated that PDE3A co-

76 Immunohistochemical staining demonstrated that talin S42

77 Immunohistochemical staining demonstrated that tau fragm

78 Immunohistochemical staining detected Cry2 in the hemisp

79 ke transcript 3(+) /4(+) ); (2) liver biopsy immunohistochemical staining (e.g., FOXP3:CD3 and CD4:CD

80 AiHp found by immunohistochemical staining especially in corpus biopsi

81 response to photostimulation and verified by immunohistochemical staining following juxtacellular lab

82 Immunohistochemical staining for adipophilin was perform

83 Immunohistochemical staining for ALDH1 on a tissue micro

84 lar investigation of deceased children using immunohistochemical staining for beta-APP and ubiquitin

85 Immunohistochemical staining for beta-catenin, cellular

86 We then used dual immunohistochemical staining for c-Fos and tryptophan hy

87 d tryptophan hydroxylase in the DR or single immunohistochemical staining for c-Fos in the basolatera

88 Immunohistochemical staining for C4d, CD20, CD138, and p

89 vo CT aiding image registration, followed by immunohistochemical staining for CD68 (macrophage densit

90 like macrophages per slice was quantified by immunohistochemical staining for CD86 as well as inducib

91 tes-associated renal matrix accumulation and immunohistochemical staining for collagens III and IV an

92 These MR results were verified by classic immunohistochemical staining for CTB, in the same animal

93 Here we identify by immunohistochemical staining for cytokeratin CK5/6 or CK

94 Both routine staining and immunohistochemical staining for cytokeratin were used a

95 y and quantitatively with full 3-dimensional immunohistochemical staining for EGFr target expression.

96 sired level of sensitivity and specificity), immunohistochemical staining for either LC3 or p62 could

97 rtrate-resistant acid phosphatase (TRAP) and immunohistochemical staining for five bone metabolism-re

98 Immunohistochemical staining for FOXA1 in a clinical pro

99 Immunohistochemical staining for GABA in GAD67-GFP mice

100 The immunohistochemical staining for GnRH in the ovary incre

101 Immunohistochemical staining for HIF1/2alpha was perform

102 Immunohistochemical staining for ICAM-1, P-selectin, nit

103 Immunohistochemical staining for infiltrating immune cel

104 Light and electron microscopy and immunohistochemical staining for markers of cellular inj

105 In patients with LS with MSI-H/I tumors, immunohistochemical staining for MMR-D was assessed.

106 Extensive immunohistochemical staining for myofibroblasts and proc

107 es and Measures: Histopathological analysis, immunohistochemical staining for p16INK4a and Ki67, HPV-

108 Immunohistochemical staining for PD-L1, PD-L2, CD8, and

109 ed as benign or ambiguous, were subjected to immunohistochemical staining for phosphohistone H3 and M

110 hatic vessel density (LVD) was determined by immunohistochemical staining for podoplanin.

111 Immunohistochemical staining for protein gene product 9.

112 Immunohistochemical staining for PTB and SRp20 of two sp

113 rate-resistant acid phosphatase reaction and immunohistochemical staining for receptor activator of n

114 Immunohistochemical staining for RUNX1 showed reactivity

115 ampling device, the Cytosponge, coupled with immunohistochemical staining for the biomarker Trefoil F

116 d by analysis of changes in tumor growth and immunohistochemical staining for the endothelial markers

117 Immunohistochemical staining for the granule protein, ma

118 Cigarette smoke caused a marked increase in immunohistochemical staining for the myeloperoxidase-gen

119 Immunohistochemical staining for three gene products con

120 GPs underwent immunohistochemical staining for TRPV1.

121 Histopathologic findings and immunohistochemical staining for tumor markers and for c

122 Brightfield immunohistochemical staining for Ucn 1 and CART showed t

123 Immunohistochemical stainings for calprotectin in renal

124 Routine histopathology and immunohistochemical stainings for CD3, CD4, CD8, CD25, F

125 Immunohistochemical stainings for myelin and oligodendro

126 Hematoxylin-eosin and immunohistochemical stainings for tumor-infiltrating lym

127 Immunohistochemical staining, gene expression profiling,

128 Evaluated by immunohistochemical staining, HCC tissues showed signifi

129 Immunohistochemical staining identified additional benef

130 Specimens were also analyzed by immunohistochemical staining identifying the laminin (Ln

131 ity of di- and tetranucleotides (EMAST), and immunohistochemical staining illustrated a complete loss

132 nd analyzed for tumor size and number and by immunohistochemical staining, immunoblot, and quantitati

133 analyses of the SUVmax of PCA, validated by immunohistochemical staining in 62 tissue samples, showe

134 rstitial trophoblasts (IT) were assessed via immunohistochemical staining in abruption-associated PTD

135 Immunohistochemical staining in an aromatase reporter mo

136 opsin, we demonstrated by immunoblotting and immunohistochemical staining in HEK-293 cells expressing

137 Immunohistochemical staining in neonatal rat cardiomyocy

138 cell populations were analyzed by performing immunohistochemical staining in primary breast cancer ti

139 Serum tryptase levels and tryptase immunohistochemical staining in skin biopsies were also

140 in TILs, defined as greater than 5% positive immunohistochemical staining in the respective cell popu

141 Immunohistochemical staining indicated that the tissue f

142 Finally, immunohistochemical staining, indirect immunofluorescenc

143 The PD-L1 immunohistochemical staining intensity of 78 treated BCC

144 s with a high SUV in vivo also showed a high immunohistochemical staining intensity.

145 GluA4 homomers (Ca(2+)-permeable AMPAR) and immunohistochemical staining localized the increase in G

146 ls that complement radiochemical imaging and immunohistochemical staining methods.

147 d hypothalamus using a range of standard and immunohistochemical staining methods.

148 On immunohistochemical staining, OATP1B1/3 expression was t

149 tion between HSF-1 and Slug was confirmed by immunohistochemical staining of a cohort of 100 invasive

150 Immunohistochemical staining of a large panel of primary

151 Immunohistochemical staining of a SCCHN tumor cohort (n

152 Immunohistochemical staining of a tissue array covering

153 s-reactivity with GD3, resulting in positive immunohistochemical staining of all 13 non-neural normal

154 s commonly based on hematoxylin and eosin or immunohistochemical staining of biopsies, which requires

155 Immunohistochemical staining of bone marrow biopsies fro

156 These results were confirmed by immunohistochemical staining of brain tissue sections re

157 ctor 1alpha and hexokinase-2, as assessed by immunohistochemical staining of carotid endarterectomy s

158 Immunohistochemical staining of embryos confirms the occ

159 Immunohistochemical staining of endobronchial biopsies i

160 Immunohistochemical staining of endobronchial biopsies r

161 BAP1 expression was evaluated by immunohistochemical staining of formalin-fixed, paraffin

162 rm memory task (object recognition task) and immunohistochemical staining of glial fibrillary acidic

163 Immunohistochemical staining of healthy tissues revealed

164 ecificity was verified by immunoblotting and immunohistochemical staining of HEK-293 cells expressing

165 By immunohistochemical staining of hepatic tumor tissue fro

166 esented for an IalphaIHC2-APLP2 complex, and immunohistochemical staining of human atherosclerotic le

167 Immunohistochemical staining of human cancers for endoge

168 Immunohistochemical staining of human IgG1 in sections o

169 Surprisingly, immunohistochemical staining of human retinal tissue rev

170 Immunohistochemical staining of infected human dental pu

171 Immunohistochemical staining of intervertebral discs of

172 ation were tested by metabolic follow-up and immunohistochemical staining of intraadrenal grafts.

173 e actin and CXCR3 expression was examined by immunohistochemical staining of IPF surgical lung biopsi

174 FSTL-1 expression patterns were analyzed by immunohistochemical staining of joint tissue derived fro

175 We performed an immunohistochemical staining of Ki67 and TUNEL and quant

176 onavirus 2 (SARS-CoV-2) infection by RT-PCR, immunohistochemical staining of kidney biopsy samples fo

177 Immunohistochemical staining of LC3-II in ONH sections f

178 ecipitation (IP), chromatin IP as well as by immunohistochemical staining of liver and tumor tissue s

179 ss"-associated markers was also evaluated by immunohistochemical staining of liver and tumor tissue s

180 Immunohistochemical staining of liver sections from thes

181 Immunohistochemical staining of liver sections revealed

182 Immunohistochemical staining of LS-positive MSI-H/I tumo

183 Interestingly, immunohistochemical staining of lung and breast cancer t

184 Immunohistochemical staining of mice and human brain sli

185 , with highest expression at maturation, and immunohistochemical staining of mouse incisors confirmed

186 Immunohistochemical staining of MTA1 was done on archiva

187 Immunohistochemical staining of murine joint sections de

188 Immunohistochemical staining of myocardial tissue showed

189 Our immunohistochemical staining of NST cells further verifi

190 EdU staining is compatible with immunohistochemical staining of other antigens.

191 Immunohistochemical staining of PANC-1 tumor xenografts

192 hematoxylin-eosin-stained sections with (2) immunohistochemical staining of paraffin sections using

193 Immunohistochemical staining of patient samples revealed

194 Immunohistochemical staining of PD-L1 expression in meni

195 Finally, by immunohistochemical staining of primary breast tissue mi

196 Immunohistochemical staining of primary CCPAP tumor spec

197 Our data support the role of BAP1 immunohistochemical staining of primary uveal melanoma t

198 the direct regulation of Tbx5 on Pcsk6 using immunohistochemical staining of pSHF, ChIP-quantitative

199 Immunohistochemical staining of RANKL and osteoclast act

200 in phosphorylation were confirmed in vivo by immunohistochemical staining of rat retinas during light

201 Immunohistochemical staining of samples obtained from br

202 Immunohistochemical staining of skin lesions showed incr

203 reatic hormones in plasma, histochemical and immunohistochemical staining of small intestine, heart,

204 Immunohistochemical staining of subtype 2 of SK protein

205 mRNA expression in arterial tissues, robust immunohistochemical staining of talin 1 was demonstrated

206 mine the temporal range of response by using immunohistochemical staining of the apoptosis marker cle

207 Ki-67 immunohistochemical staining of the arthritic ankles and

208 an isolated retina was measured, followed by immunohistochemical staining of the axonal cytoskeleton.

209 Immunohistochemical staining of the DOT1L protein in mou

210 Immunohistochemical staining of the hippocampus detected

211 Furthermore, immunohistochemical staining of the NFPAs clinical sampl

212 Immunohistochemical staining of the RHE model identified

213 oth corresponding sites obtained by means of immunohistochemical staining of the selected histologic

214 Immunohistochemical staining of tissue from a series of

215 Immunohistochemical staining of tissue microarrays (TMAs

216 In patients, immunohistochemical staining of tissue microarrays and m

217 Immunohistochemical staining of tissues from patients wi

218 VDR and RXR expression were assessed by immunohistochemical staining of tumor microarrays (n = 6

219 sualized, and uptake correlated with ex vivo immunohistochemical staining of tumor vasculature.

220 Immunohistochemical staining of urinary exfoliated cells

221 s from the TCGA data mining and validated by immunohistochemical staining on colorectal cancer tissue

222 Immunohistochemical staining on formalin-fixed BCCs from

223 Standard-of-care frozen section and immunohistochemical staining on permanent sections were

224 s were analyzed for caveolin-1 expression by immunohistochemical staining or Western blotting, respec

225 ho-tau Ser202 and Thr205) and CP13 (pSer202) immunohistochemical stainings] pathological inclusions,

226 gic pRCC subtype in combination with the MYC immunohistochemical staining patterns allows a more accu

227 the clinical presentation and the results of immunohistochemical staining patterns are distinctive.

228 ted with ELF5 expression, and increased ELF5 immunohistochemical staining predicted much shorter meta

229 d to show that conventional histological and immunohistochemical staining protocols are compatible wi

230 Immunohistochemical staining revealed cleaved caspase-3

231 Finally, immunohistochemical staining revealed elevated pVHL and

232 Immunohistochemical staining revealed GSK3beta to be foc

233 Immunohistochemical staining revealed increased astrocyt

234 Immunohistochemical staining revealed intense MUC-2 secr

235 Periodic acid-Schiff and immunohistochemical staining revealed mucous cell metapl

236 Finally, immunohistochemical staining revealed reduced concentrat

237 Immunohistochemical staining revealed stronger tumor cel

238 Finally, immunohistochemical staining revealed supra-basal expres

239 Immunohistochemical staining revealed that cholinergic a

240 Immunohistochemical staining revealed the presence of en

241 Immunohistochemical staining revealed the tumour cells t

242 Immunohistochemical stainings revealed that the alpha3 G

243 Immunohistochemical staining reveals that both PEL and K

244 For immunohistochemical staining, samples from 26 subjects w

245 Furthermore, immunohistochemical staining showed decreased Ki67 and u

246 Immunohistochemical staining showed extensive depletion

247 Immunohistochemical staining showed increased expression

248 Immunohistochemical staining showed macrophages, granulo

249 Immunohistochemical staining showed more ionized calcium

250 Immunohistochemical staining showed significant reactive

251 Immunohistochemical staining showed strong staining of C

252 Immunohistochemical staining showed that acute AD lesion

253 Immunohistochemical staining showed that Foxa1/a2 mutant

254 Immunohistochemical staining showed that hMSC-derived en

255 Immunohistochemical staining showed that RNF41 expressio

256 Immunohistochemical staining showed that TGLI1, but not

257 Immunohistochemical staining showed that TiO(2) coating

258 Consistent with the mouse model study, immunohistochemical staining showed that ZO-1 is abundan

259 Immunohistochemical stainings showed altered cell compos

260 nd its results were correlated with those of immunohistochemical staining specific for myelin, iron,

261 Immunohistochemical staining strongly correlated the co-

262 Immunohistochemical staining suggests that capa accumula

263 e to have greater numbers of lymphocytes, by immunohistochemical staining, than did BALB wild type li

264 In the present study, we have found by immunohistochemical staining that both LXRalpha and LXRb

265 Based on immunohistochemical staining, the tumor xenografts in mi

266 vidual mice and some readout parameters (eg, immunohistochemical staining), this was not the case for

267 We used immunohistochemical staining to validate the results.

268 Immunohistochemical staining using anti-CRB1 yielded pos

269 and mass spectrometry, was confirmed by dual immunohistochemical staining using commercial antibodies

270 Immunohistochemical staining verified increased HSP27 an

271 Immunohistochemical staining was performed for the activ

272 Immunohistochemical staining was performed to evaluate t

273 Immunohistochemical staining was performed to identify c

274 l suture model in BALB/c mice was placed and immunohistochemical staining was performed with CD31/PEC

275 Immunohistochemical staining was performed with polyclon

276 ts of animals characterized at G90 and G135, immunohistochemical staining was performed, and 3D struc

277 E), and if the SN was negative with HE, then immunohistochemical staining was performed.

278 Immunohistochemical staining was used to analyze EGFR ex

279 Immunohistochemical staining was used to determine IgG(b

280 Immunohistochemical staining was used to evaluate protei

281 Immunohistochemical staining was used to identify active

282 Immunohistochemical staining was used to localize VEGFR2

283 To confirm the presence of macrophages, CD68 immunohistochemical staining was used.

284 Using immunohistochemical staining, we demonstrate that TXNDC5

285 rus load because equivalent virus titers and immunohistochemical staining were observed in the nasal

286 Drug pharmacokinetics and N-cadherin immunohistochemical staining were performed on pretreatm

287 Quantitative real-time PCR and immunohistochemical staining were performed to confirm t

288 Hematoxylin-eosin (HE) and immunohistochemical staining were performed to evaluate

289 Whole-body fluorescence imaging and immunohistochemical staining were performed to validate

290 d tartrate-resistant acid phosphatase (TRAP) immunohistochemical staining were performed.

291 Tract tracing and immunohistochemical staining were used to determine whet

292 Besides histomorphologic evaluation, the immunohistochemical stainings were analyzed for the resp

293 Further, immunohistochemical staining, which was performed in 20

294 Immunohistochemical staining with a hepatocyte-specific

295 orption via scanning electron microscopy and immunohistochemical staining with an anti-EMD antibody.

296 Immunohistochemical staining with an antibody specific f

297 ned in paraffin-embedded tumor tissues using immunohistochemical staining with peroxidase-catalyzed p

298 ed by scanning electron microscopy (SEM) and immunohistochemical staining with subsequent laser-scann

299 to 25 weeks according to flow cytometry and immunohistochemical staining, with partial to full recov

300 ction protein in heart and lung specimens by immunohistochemical staining within 3 hours.